NNS 2015 Program & Abstract Book

30 / 198

27
CME & Disclosures
CME & Disclosure Information
Disclosure of Con icts
Continuing Medical Education
Bansal, Vishal
Consultant: Oxeia Biopharmaceuticals
Bond, Lisa
Employee: BioAxone BioSciences, Inc.
Borlongan, Cesar
Grant Recipient: Karyopharm Inc.
Shareholder: Sanbio Inc.
Dhall, Sanjay
Honorarium Recipient:
Depuy Spine (JNJ)
Globus Spine
Dietrich, W. Dalton
Speakers Bureau: Zoll Medical
Gioia, Gerard
Royalty Recipient: Psychological
Assessment Resources, Inc.
Kannan, Sujatha
Holder of Intellectual Property Rights:
Glia Therapeutics
Kiderman, Alexander
Employee: Neuro Kinetics, Inc.
Kochanek, Patrick
Holder of Intellectual Property Rights:
Patent No.# US 8,628,512 B2
Grant Recipient: NIH and US Army
Kwon, Brian
Advisor/Review Panel: Acorda Therapeutics
Layer, Richard
Employee: InVivo Therapeutics
Morioka, Kazuhito
Grant Recipient:
NIH (NS088475, NS067092)
Craig H. Neilsen Foundation
Wings for Life Spinal Cord Research Found.
Samadani, Uzma
Shareholder: Oculogica Inc.
Smith, William
Consultant, Shareholder & Honorarium
Recipient: NuVasive, Inc.
Thelin, Eric
Speakers Bureau: Roche Diagnostics
Vitek, Mike
Holder of Intellectual Property Rights:
Cognosci, Inc.
Oncotide Pharmaceuticals, Inc.
Wang, Kevin
Shareholder: Banyan Biomarkers, Inc.
Yonan, Charles
Employee: Avanir Pharmaceuticals, Inc.
The following speakers, chairs, presenting authors and/or Program Committee members report the following relevant relationships:
Adhering to the ACCME Standards (see ), all relationships reported have been resolved according to VCU’s Policy on Con ict of Interest.
All presenting faculty a rm that they will employ the best available evidence from all sources to support any clinical recommendations made in their
presentations. If learners detect any commercial bias in any presentation, they should document their observations on the Activity Evaluation Form.
Speakers Bureau:
This activity has been planned and implemented in accordance with the accreditation statement and policies of the Accreditation Council for Continuing Medical Education (ACCME)
through the joint providership of University Health Services Professional Education Programs (UHS-PEP) of Virginia Commonwealth University Health System and the National
Neurotrama Society. UHS-PEP is accredited by the ACCME to provide continuing medical education for physicians.
UHS-PEP designates this live activity for a maximum of 31.5 AMA PRA Category 1 Credits(TM) Physicians should claim only the credit commensurate with the extent of their
participation in the activity.
Credits are designated as follows:
- UHS-PEP designates a maximum of 23.25 CME credits for the National Neurotrauma
Society sponsored portion of the entire symposium.
- The optional WiNTR lunch session is 1.25 CME credits.
- The optional WiNTR mentoring reception is 1.0 CME credit.
- The AANS/CNS sponsored program is designated for a maximum of 6.0 CME credits.
This continuing education activity meets the criteria of Virginia Commonwealth University and the Southern Association of Colleges and Schools. 3.15 CEUs will be awarded and
recorded with the University (if all sessions are completed as described above).
Claiming CME or CEU Credit
Educational Learning Objectives
To claim CME or CEU credits for the meeting:
1. Complete the CME Survey questions for EACH DAY you attend.
You will receive an email evaluation survey at the end of the conference. On the submission con rmation page for the survey, you will receive a CME ACCESS CODE.
2. Login to your NNS account and click on the“Claim CMEs” link.
Enter the CME Access Code and select the sessions you attended. Your CME certi cate will be available instantly in your NNS account under“CME Certi cates”.
At the conclusion of this three day symposium, attendees will be able to:
I. Describe injury models and novel approaches to study traumatic brain and spinal cord injury.
II. Identify advances in therapeutic targeting to enhance outcome after central nervous system injury.
III. Discuss controversial issues in the translation of therapeutic treatments from the laboratory to the clinic.